✦ LIBER ✦

Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells

✍ Scribed by Matthias Peiper; Peter S Goedegebuure; Timothy J Eberlein

Book ID: 117220790
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 822 KB
Volume: 122
Category: Article
ISSN: 0039-6060
DOI: 10.1016/s0039-6060(97)90014-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Generation of Primary Peptide-Specific C

Generation of Primary Peptide-Specific CD8 Cytotoxic T-Lymphocytes In Vitro Using Allogeneic Dendritic Cells

✍ Peshwa, M 📂 Article 📅 1998 🏛 Cognizant Communication Corporation 🌐 English ⚖ 103 KB

Generation of Potent Cytotoxic T Lymphoc

Generation of Potent Cytotoxic T Lymphocytes Against Castration-Resistant Prostate Cancer Cells by Dendritic Cells Loaded With Dying Allogeneic Prostate Cancer Cells

✍ Hwang, E. C.; Lim, M.-S.; Im, C.-M.; Kwon, D.-D.; Lee, H.-J.; Nguyen-Pham, T.-N. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

Cytotoxic T lymphocyte mediated recognit

Cytotoxic T lymphocyte mediated recognition of human pancreatic cancer cells

✍ Matthias Peiper; Takeo Sato; Thomas Streichert; Claus Ferdinand Eisenberger; Wol 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB

## Abstract T lymphocytes play an important role in tumor rejection and their response to human malignant melanoma has been well documented. In contrast, the existence of cytotoxic T lymphocytes (CTL) to pancreatic cancer remains unclear. Tumor‐associated lymphocytes (TAL) and peripheral blood mono

In vitro priming of tumor-specific cytot

In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line

✍ Saskia J. A. M. Santegoets; Marco W. J. Schreurs; Allan J. Masterson; Ying Poi L 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 391 KB

Detection of peptide-specific cytotoxic

Detection of peptide-specific cytotoxic T-lymphocyte precursors used for specific immunotherapy of pancreatic cancer

✍ Nobuaki Suzuki; Yoshiaki Maeda; Shoko Tanaka; Naoya Hida; Takashi Mine; Koutaro 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 143 KB

## Abstract The prognosis of pancreatic cancer is extremely poor with a 5‐year survival of approximately 3%. Thus, the development of new treatment modalities, including a specific immunotherapy, is required. Our study investigated whether cytotoxic T‐lymphocyte (CTL) precursors reacting to peptide

Generation of cytotoxic T lymphocytes to

Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells

✍ ZARLING, JOYCE M.; ROBINS, H. IAN; RAICH, PETER C.; BACH, FRITZ H.; BACH, MARILY 📂 Article 📅 1978 🏛 Nature Publishing Group 🌐 English ⚖ 350 KB